Participated · Series A · Aug 2026

Founded in June 2021 by Oh Hyun-ung, Step Lab develops space-grade mechanism technology including a launch-vibration-reducing separation ring used to connect and detach satellites from launch vehicles. Its flagship products include the separation ring and STEP POD, a CubeSat deployer that integrates an in-house vibration isolation system and is slated to fly aboard DaejeonSAT-1, giving the company its first flight heritage. Step Lab has expanded into payload technology, building a 4-meter-class, three-stage deployable SAR mesh antenna and developing an AI-based zoom optical module for space domain awareness through Korea’s Scale-up TIPS program. The company has also developed full small-satellite systems-integration capability via its DaejeonSAT-1 work, which will carry a selfie camera to confirm on-orbit status. With the recent Series A, Step Lab plans to scale mass production of its flight-proven mechanisms and accelerate global commercialization.

Participated · Series B · Jun 2026

Promedius develops Osteo Signal, an AI-based screening solution that analyzes routine chest radiographs to assess osteoporosis risk in about three seconds and identify at-risk patient groups without additional tests. Osteo Signal was designated an innovative medical device in 2024 and received approval from the Korean Ministry of Food and Drug Safety in 2025; the company has also secured regulatory approvals in Vietnam and Indonesia and is seeking FDA and CE/MDR clearances by the end of the year. Promedius has built partnerships with global medical device companies such as Siemens Healthineers and secured strategic investors including Daewoong Pharmaceutical and Naver to support commercial rollout. The company aims to commercialize nationally and expand internationally while broadening its platform to address healthy aging conditions like sarcopenia, metabolic and cardiovascular diseases. Its total funding now exceeds 35 billion won following the recent Series B raise of 21.5 billion won.

Participated · Series B · Feb 2026

Galux leverages its proprietary GaluxDesign platform, which integrates deep-learning with biophysical principles, to design high-affinity antibodies and other proteins from scratch. The platform has already produced antibodies whose AI-predicted structures align closely with cryo-EM data, validating its precision and generalizability. Galux is expanding the technology to harder target classes such as GPCRs and ion channels while tightly coupling AI modeling with wet-lab feedback to speed iteration. The company has formed co-development partnerships with Celltrion, LG Chem, and most recently Boehringer Ingelheim to broaden its pipeline and global reach. Proceeds from the latest financing will enhance the AI engine, grow R&D infrastructure, and advance proprietary programs into preclinical validation. Since its 2022 $18 million Series A, Galux has hit multiple R&D and business milestones, helping it secure the follow-on funding. Cumulatively, the company has raised $47 million to date.

Participated · Series B · May 2024

Medintech develops a motorized, 50% lighter gastrointestinal endoscope and complementary AI software to detect abnormal regions and reduce misdiagnosis. The company’s founders spun out of the Korea Electrotechnology Research Institute and established the business in 2020. It holds Class II medical device approval for its motorized GI endoscope system and its anomaly‑detection software. Medintech is conducting clinical trials with Seoul National University Hospital and plans full market entry within the year. The company intends to further refine its AI convenience features to maximize the utility and ease of its motorized endoscope. Proceeds from its latest financing will be used to establish mass production capabilities and support overseas expansion. Cumulatively, Medintech has raised more than ₩28 billion to date.

Participated · Series B · Sep 2023

AB180, founded in 2015 and based in Seoul, South Korea, builds marketing-technology software to help businesses optimize marketing through data-driven measurement. Its flagship product AirBridge measures and assesses user behavior and advertising impact across mobile applications and websites. The company also offers enterprise tools including the product-analysis tool Amplitude and the marketing automation solution Blaze. AB180 counts clients such as GS Home Shopping, SC First Bank, SK Telecom, Burger King, Kakao Style, Queenit, and Toss. Its platform is available in more than 20 countries (including the U.S., Canada, Vietnam, and Malaysia) and reaches over 54 million devices across 200 countries, analyzing advertising and customer data. The business plans to use new funding to support international expansion, customer acquisition, strengthen its technological foundation, enhance infrastructure, and refine service capabilities. The company raised KRW12.0B in a Series B in August 2023, improving its financial resources for growth.